Cargando…

The “Sandwich” Schedule: A Well-Tolerated Adjuvant Treatment Both in Intermediate–High- and High-Risk Endometrial Cancer

(1) Background: In intermediate–high- and high-risk endometrial cancer (EC), radiotherapy (RT) and chemotherapy (CT) play a basic role. However, there is controversy regarding the optimal timing of their combination. The “sandwich” schedule involves adjuvant CT followed by RT and subsequent CT. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrero, Annamaria, Fuso, Luca, Cipullo, Isabella, Danese, Roberta, Rossi, Annalisa, Gribaudo, Sergio, Attianese, Daniela, Pace, Luca, Danese, Saverio, Biglia, Nicoletta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776555/ https://www.ncbi.nlm.nih.gov/pubmed/36547136 http://dx.doi.org/10.3390/curroncol29120722

Ejemplares similares

Immunohistochemical Markers and TILs Evaluation for Endometrial Carcinoma
por: Bounous, Valentina Elisabetta, et al.
Publicado: (2022)

Clinical, Sonographic, and Hysteroscopic Features of Endometrial Carcinoma Diagnosed after Hysterectomy in Patients with a Preoperative Diagnosis of Atypical Hyperplasia: A Single-Center Retrospective Study
por: Pace, Luca, et al.
Publicado: (2022)

One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients
por: De Sanctis, Vitaliana, et al.
Publicado: (2020)

Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients
por: Rosso, Roberta, et al.
Publicado: (2023)

Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience
por: Tuninetti, Valentina, et al.
Publicado: (2023)

Low-Grade Uterine Endometrial Stromal Sarcoma: Prognostic Analysis of Clinico-Pathological Characteristics, Surgical Management, and Adjuvant Treatments. Experience From Two Referral Centers
por: Borella, Fulvio, et al.
Publicado: (2022)

Immunonutrition in ovarian cancer: clinical and immunological impact?
por: Ferrero, Annamaria, et al.
Publicado: (2022)

Adjuvant chemo-radiotherapy in the “sandwich” method for high risk endometrial cancer—a review of literature
por: Bie, Yachun, et al.
Publicado: (2015)

Sequential chemotherapy and radiotherapy as sandwich therapy for the treatment of high risk endometrial cancer
por: Abaid, Lisa N., et al.
Publicado: (2012)

Concerns and Expectations of Risk-Reducing Surgery in Women with Hereditary Breast and Ovarian Cancer Syndrome
por: Modaffari, Paola, et al.
Publicado: (2019)

Predictors of Survival in Women with High-Risk Endometrial Cancer and Comparisons of Sandwich versus Concurrent Adjuvant Chemotherapy and Radiotherapy †
por: Chen, Hui-Hua, et al.
Publicado: (2020)

Can Vulnerable Elders Survey-13 predict the impact of frailty on chemotherapy in elderly patients with gynaecological malignancies?
por: Ferrero, Annamaria, et al.
Publicado: (2018)

Predicting Response to Anthracyclines in Ovarian Cancer
por: Ferrero, Annamaria, et al.
Publicado: (2022)

Laparoscopic surgery for low, intermediate and high-risk endometrial cancer
por: Vardar, Mehmet Ali, et al.
Publicado: (2018)

Daily administration of low molecular weight heparin increases Hepatocyte Growth Factor serum levels in gynaecological patients: pharmacokinetic parameters and clinical implications
por: Surbone, Anna, et al.
Publicado: (2012)

Medical treatment of early stage and rare histological variants of epithelial ovarian cancer
por: Cont, Nicoletta Tomasi, et al.
Publicado: (2015)

Outcomes of “sandwich” chemoradiotherapy compared with chemotherapy alone for the adjuvant treatment of FIGO stage III endometrial cancer
por: Wang, Shao-Jing, et al.
Publicado: (2022)

Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group
por: Reboux, Pierre-Alain, et al.
Publicado: (2019)

Open Surgery including Lymphadenectomy without Adjuvant Therapy for Uterine-Confined Intermediate- and High-Risk Endometrioid Endometrial Carcinoma
por: Otsuka, Isao, et al.
Publicado: (2022)

Role of systematic lymphadenectomy in patients with intermediate to high-risk early stage endometrial cancer
por: Kim, Nae Ry, et al.
Publicado: (2022)

FOXA1 in Breast Cancer: A Luminal Marker with Promising Prognostic and Predictive Impact
por: Metovic, Jasna, et al.
Publicado: (2022)

Nerve preserving vs standard laparoscopic sacropexy: Postoperative bowel function
por: Cosma, Stefano, et al.
Publicado: (2017)

A multi-institutional analysis of sequential versus ‘sandwich’ adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma
por: Onal, Cem, et al.
Publicado: (2018)

Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT)
por: Li, Yang, et al.
Publicado: (2023)

Quality of life and sexual functioning among endometrial cancer patients treated with one week adjuvant high-dose-rate vaginal brachytherapy schedule
por: Facondo, Giuseppe, et al.
Publicado: (2022)

Should the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade?
por: Lan, Chunyan, et al.
Publicado: (2015)

Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy
por: Wortman, B. G., et al.
Publicado: (2018)

The Role of Para-Aortic Lymphadenectomy in the Surgical Staging of Women with Intermediate and High-Risk Endometrial Adenocarcinomas
por: May, Taymaa, et al.
Publicado: (2013)

Identifying a molecular profile to predict the risk of recurrence in high‐intermediate risk endometrial cancer
por: Arend, Rebecca C., et al.
Publicado: (2021)

The Retrograde and Retroperitoneal Totally Laparoscopic Hysterectomy for Endometrial Cancer
por: Volpi, Eugenio, et al.
Publicado: (2012)

Sequential Chemotherapy and Radiotherapy in the Sandwich Method for Advanced Endometrial Cancer: A Meta-Analysis
por: Gao, Huiqiao, et al.
Publicado: (2015)

PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer
por: van den Heerik, Anne Sophie V M, et al.
Publicado: (2020)

Improving locoregional outcome in high-intermediate-risk and high-risk stage I endometrial cancer with surgical staging followed by brachytherapy
por: Abakay, Candan Demiroz, et al.
Publicado: (2022)

Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging
por: Cusimano, Maria C., et al.
Publicado: (2020)

Avoiding Full Lymphadenectomies in Intermediate- and High-Risk Endometrial Cancer by Sentinel Lymph Node Biopsy Implementation
por: Pineda, Virginia García, et al.
Publicado: (2021)

Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers
por: Borella, Fulvio, et al.
Publicado: (2022)

Correction: Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers
por: Borella, Fulvio, et al.
Publicado: (2022)

What is terrorism? A book to help parents, teachers and other grown-ups talk with kids about terror
por: Danese, Andrea
Publicado: (2018)

Gut eukaryotic virome in colorectal carcinogenesis: Is that a trigger?
por: Massimino, Luca, et al.
Publicado: (2020)

Going Beyond Bacteria: Uncovering the Role of Archaeome and Mycobiome in Inflammatory Bowel Disease
por: Houshyar, Yashar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_riaqb6735ii3lhrflrlc2ne59t